Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycophenolate Mofetil in Sjogren's Syndrome
NCT02691949Phase 2Unknown
- Sponsor
- Kaohsiung Medical University
- Start
- Feb 2016
- Primary completion
- Apr 2018
- Modality
- Small Molecules
01
Overview
Phase 2, randomised trial of mycophenolate mofetil in Sjogren's syndrome (2 arms), sponsored by Kaohsiung Medical University. Primary endpoint: Change of Composite Index of Sjogren's syndrome at 28 weeks. Status: unknown.
02
Drugs
mycophenolate mofetil
03
Conditions
Sjogren's syndrome
Beyond the preview
Go deeper on NCT02691949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02691949.